Zyrtec OTC
Selected indexed studies
- OTC product: Zyrtec and Zyrtec-D 12 hour. (J Am Pharm Assoc (2003), 2008) [PMID:18359738]
- OTC drugs for seasonal allergies. (Med Lett Drugs Ther, 2019) [PMID:31169808]
- The Rx-to-OTC switch of Claritin, Allegra, and Zyrtec: an unprecedented FDA response to petitioners and the protection of public health. (Am Univ Law Rev, 2002) [PMID:12197546]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- OTC drugs for seasonal allergies. (2019) pubmed
- In brief: OTC alcaftadine (Lastacaft Once Daily Relief) for allergic conjunctivitis. (2022) pubmed
- Safety of fexofenadine and other second-generation oral antihistamines before and after the removal of the prescription requirement in Italy and other European countries: A real-world evidence study and systematic review. (2022) pubmed
- OTC product: Zyrtec and Zyrtec-D 12 hour. (2008) pubmed
- Nonprescription medications for respiratory symptoms: Facts and marketing fictions. (2018) pubmed
- The effectiveness of levocetirizine in comparison with loratadine in treatment of allergic rhinitis--a meta-analysis. (2011) pubmed
- COVID-19 self-medication treatment: Media's adverse effect based on people's level of education. (2023) pubmed
- Therapeutic advantages of third generation antihistamines. (1998) pubmed
- The Rx-to-OTC switch of Claritin, Allegra, and Zyrtec: an unprecedented FDA response to petitioners and the protection of public health. (2002) pubmed
- Now you see it. Now you don't: fair balance and adequate provision in advertisements for drugs before and after the switch from prescription to over-the-counter. (2012) pubmed